Browsing: Failure

Sotagliflozin, an innovative drug approved by the Food and Drug Administration, represents a significant advancement in the treatment of type…

In a groundbreaking study, researchers at Nagoya University Graduate School of Medicine have unveiled an exciting potential therapeutic target for…

In a significant nationwide cohort study conducted in the Republic of Korea, researchers have uncovered a concerning correlation between postdiagnosis…